FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Humulin N (insulin isophane (NPH))

Snippet

SUPPL AP for HUMULIN N (INSULIN HUMAN)